STAT4 regulates complement factor H (CFH) in lung cancer, which inhibits the complement system and mediates resistance to therapy with monoclonal antibodies, which generally enhances complement activation leading to cellular cytotoxicity. The gene discussed is CFH; the disease is lung carcinoma.